1-(4-iodophenyl)ethane-1,2-diol | 1426913-89-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(4-iodophenyl)ethane-1,2-diol
• CAS: 1426913-89-4
• 化学式: C₈H₉IO₂
• 分子量: 264.063
• InChiKey: ZNNCSCNNQXKILF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(4-iodophenyl)ethane-1,2-diol 在 C₃₀H₂₉BrMnNO₂P₂ 、 potassium hydroxide 作用下， 以 2-甲基-2-丁醇 为溶剂， 反应 8.0h， 以61%的产率得到
  参考文献：
  名称：

  释放氢气的锰催化邻二醇重整为α-羟基羧酸

  摘要：

  通过环保催化途径将现成的原料转化为有价值的平台化学品一直是合成化学家关注的重点之一。在此背景下，我们报告了将容易获得的原料（邻二醇）选择性转化为在生物活性分子和可生物降解聚合物中普遍存在的增值α-羟基羧酸分子。一种稳定的地球丰富的金属配合物，{[HN(C 2 H 4 PPh 2 ) 2 ]Mn(CO) 2 Br}，Mn-I在低温下以高选择性催化重整反应，周转数达到2400，超过了以前用于该反应的均相催化剂。氢气作为副产品释放，不需要受体。开发的协议适用于芳香族和脂肪族邻二醇，以高产率和选择性提供α-取代的羟基羧酸。详细的机理研究阐明了在这种无受体脱氢催化过程中不同锰 (I) 物种的参与。

  DOI：

  10.1021/acscatal.1c05844

文献信息

• NOVEL HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF
  申请人：TOYAMA CHEMICAL CO., LTD.

  公开号：US20160039751A1

  公开（公告）日：2016-02-11

  A compound represented by general formula (1) (wherein R 1 represents a hydrogen atom, an optionally substituted C 1-6 alkyl group or the like; R 2 represents a hydrogen atom, an optionally substituted C 1-6 alkyl group or the like; R 3 represents a hydrogen atom or an optionally substituted C 1-6 alkyl group; R 4 represents a hydrogen atom, an optionally substituted C 1-6 alkyl group or the like; X 1 represents an optionally substituted C 2-6 alkynylene group or the like; A represents an optionally substituted bivalent aromatic hydrocarbon group or the like; X 2 represents an optionally substituted C 1-6 alkylene group or the like; Y 1 represents an oxygen atom or the like; and R 5 represents a hydrogen atom or the like) or a salt thereof is useful as an antibacterial agent.

  通用式（1）所代表的化合物（其中R1代表氢原子、可选择地取代的C1-6烷基或类似物；R2代表氢原子、可选择地取代的C1-6烷基或类似物；R3代表氢原子或可选择地取代的C1-6烷基；R4代表氢原子、可选择地取代的C1-6烷基或类似物；X1代表可选择地取代的C2-6炔基或类似物；A代表可选择地取代的二价芳香烃基或类似物；X2代表可选择地取代的C1-6烷基或类似物；Y1代表氧原子或类似物；R5代表氢原子或类似物）或其盐可用作抗菌剂。
• [EN] ANTIBACTERIAL 1H-INDAZOLE AND 1H-INDOLE DERIVATIVES<br/>[FR] DÉRIVÉS DE 1H-INDAZOLE ET DE 1H-INDOLE ANTIBACTÉRIENS
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2015091741A1

  公开（公告）日：2015-06-25

  The invention relates to antibacterial compounds of formula (I) wherein X is N or CH; R1 is H or halogen; R2 is alkynyloxy or the group M; R3 is H or halogen; M is one of the groups MA and MB represented below wherein A is a bond, CH2CH2, CH=CH or C≡C; R1A is H or halogen; R2A is H, alkoxy or halogen; R3A is H, alkoxy, hydroxyalkoxy, alkoxyalkoxy, thioalkoxy, trifluoromethoxy, amino, hydroxyalkyl, 2-hydroxyacetamido, 1-aminocyclopropyl, 1 -hydroxymethyl- cycloprop-l-yl, l-((phosphonooxy)methyl)cyclopropyl, l-(((dimethylglycyl)oxy)methyl)cyclopropyl, trans-2 -hydroxymethyl-cycloprop- 1-yl, 1,2-dihydroxy ethyl, 3-hydroxyoxetan-3-yl, 3-(hydroxyalkyl)oxetan-3-yl, 3-aminooxetan- 3-yl, 3-hydroxythietan-3-yl, morpholin-4-ylalkoxy, morpholin-4-yl-alkyl, oxazol-2-yl or [l,2,3]triazol-2-yl; and R1B is hydroxyalkyl, dihydroxyalkyl, aminoalkyl, 1 -hydroxymethyl-cycloprop- 1 -yl, 1 -aminomethyl-cycloprop- 1-yl, iraws-2-hydroxymethyl- cycloprop-l-yl, 3-hydroxyoxetan-3-yl, 3-hydroxythietan-3-yl, 1 -(2-hydroxyacetyl)azetidin- 3-yl, l-(2-aminoacetyl)azetidin-3-yl, l-glycylazetidin-3-yl, l-(2-amino- 2-methylpropanoyl)azetidin-3-yl, 3-(2-aminoacetamido)cyclopentyl, trans-(cis-3,4-dihydroxy)-cyclopent-1-yl or 3-hydroxymethylbicyclo [1,1, 1]pentan-1-yl; and salts thereof.

  该发明涉及式(I)的抗菌化合物，其中X为N或CH；R1为H或卤素；R2为炔氧基或基团M；R3为H或卤素；M为下面表示的MA和MB基团之一，其中A为键，CH2CH2，CH=CH或C≡C；R1A为H或卤素；R2A为H，烷氧基或卤素；R3A为H，烷氧基，羟基烷氧基，烷氧基烷氧基，硫烷氧基，三氟甲氧基，氨基，羟基烷基，2-羟基乙酰胺基，1-氨基环丙基，1-羟甲基环丙基，1-((磷酸酯氧基)甲基)环丙基，1-(((二甲基甘氨酰氧基)甲基)环丙基，反-2-羟甲基环丙基，1,2-二羟基乙基，3-羟基氧杂环戊二烯-3-基，3-(羟基烷基)氧杂环戊二烯-3-基，3-氨基氧杂环戊二烯-3-基，3-羟基硫杂环戊二烯-3-基，吗啉-4-基烷氧基，吗啉-4-基烷基，噁唑-2-基或[l,2,3]三唑-2-基；R1B为羟基烷基，二羟基烷基，氨基烷基，1-羟甲基环丙基，1-氨基甲基环丙基，反-2-羟甲基环丙基，3-羟基氧杂环戊二烯-3-基，3-羟基硫杂环戊二烯-3-基，1-(2-羟乙酰基)氮杂环丙基，1-(2-氨基乙酰基)氮杂环丙基，1-甘氨酰氮杂环丙基，1-(2-氨基-2-甲基丙酰基)氮杂环丙基，3-(2-氨基乙酰胺基)环戊基，反-(顺-3,4-二羟基)-环戊-1-基或3-羟甲基双环[1,1,1]戊烷-1-基；及其盐。
• Design and synthesis of 2-phenyl-1,4-dioxa-spiro[4.5]deca-6,9-dien-8-ones as potential anticancer agents starting from cytotoxic spiromamakone A
  作者：Shinichiro Fuse、Kennichi Inaba、Motoki Takagi、Masahiro Tanaka、Takatsugu Hirokawa、Kohei Johmoto、Hidehiro Uekusa、Kazuo Shin-ya、Takashi Takahashi、Takayuki Doi

  DOI：10.1016/j.ejmech.2013.05.030

  日期：2013.8

  The spirocycle is a key structure found in many bioactive compounds. From the cytotoxic and spirocyclic natural product, spiromamakone A (1) and its analogues, a more synthetically accessible spiroacetal template 4 was designed based on structural similarity analysis. A total of 50 compounds were rapidly synthesized in only one or two synthetic steps from the starting compound, and their cytotoxicity was evaluated. As a result, (+/-)-(2R*,5R*)-2-(4-iodophenyl)-7-chloro-1,4-dioxa-spiro[4.5]deca-6,9-dien-8-one (7d-II) was discovered and found to be fifteen-fold more cytotoxic than 1. The easily accessible spiroacetal 7d-II appeared to act in a manner similar to the highly oxidized natural product, spiromamakone A (1). (C) 2013 Elsevier Masson SAS. All rights reserved.
• ANTIBACTERIAL 1H-INDAZOLE AND 1H-INDOLE DERIVATIVES
  申请人：Actelion Pharmaceuticals Ltd

  公开号：EP3083567A1

  公开（公告）日：2016-10-26
• US9862676B2
  申请人：——

  公开号：US9862676B2

  公开（公告）日：2018-01-09